196 related articles for article (PubMed ID: 31460869)
1. Impact of Primary Antibody Clone, Format, and Stainer Platform on Ki67 Proliferation Indices in Breast Carcinomas.
Røge R; Nielsen S; Riber-Hansen R; Vyberg M
Appl Immunohistochem Mol Morphol; 2019; 27(10):732-739. PubMed ID: 31460869
[TBL] [Abstract][Full Text] [Related]
2. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
Røge R; Riber-Hansen R; Nielsen S; Vyberg M
Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
[TBL] [Abstract][Full Text] [Related]
3. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different anti-Ki67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis.
Owens R; Gilmore E; Bingham V; Cardwell C; McBride H; McQuaid S; Humphries M; Kelly P
Histopathology; 2020 Oct; 77(4):646-658. PubMed ID: 32617996
[TBL] [Abstract][Full Text] [Related]
5. Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
Ilie M; Khambata-Ford S; Copie-Bergman C; Huang L; Juco J; Hofman V; Hofman P
PLoS One; 2017; 12(8):e0183023. PubMed ID: 28797130
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience.
Røge R; Nielsen S; Riber-Hansen R; Vyberg M
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):99-104. PubMed ID: 32168036
[TBL] [Abstract][Full Text] [Related]
7. A new tool for technical standardization of the Ki67 immunohistochemical assay.
Aung TN; Acs B; Warrell J; Bai Y; Gaule P; Martinez-Morilla S; Vathiotis I; Shafi S; Moutafi M; Gerstein M; Freiberg B; Fulton R; Rimm DL
Mod Pathol; 2021 Jul; 34(7):1261-1270. PubMed ID: 33536573
[TBL] [Abstract][Full Text] [Related]
8. Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.
Horii R; Tsuda H; Masuda S; Sugita H; Togashi K; Ohno S; Akiyama F
Breast Cancer; 2020 Nov; 27(6):1058-1064. PubMed ID: 32440959
[TBL] [Abstract][Full Text] [Related]
9. Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms.
Koppel C; Schwellenbach H; Zielinski D; Eckstein S; Martin-Ortega M; D'Arrigo C; Schildhaus HU; Rüschoff J; Jasani B
Mod Pathol; 2018 Nov; 31(11):1630-1644. PubMed ID: 29946185
[TBL] [Abstract][Full Text] [Related]
10. Carb-3 is the superior anti-CD15 monoclonal antibody for immunohistochemistry.
Røge R; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):449-58. PubMed ID: 23846425
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity.
Goldstein NS; Hunter S; Forbes S; Odish E; Tehrani M
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):203-7. PubMed ID: 17525635
[TBL] [Abstract][Full Text] [Related]
12. Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer.
Adam J; Le Stang N; Rouquette I; Cazes A; Badoual C; Pinot-Roussel H; Tixier L; Danel C; Damiola F; Damotte D; Penault-Llorca F; Lantuéjoul S
Ann Oncol; 2018 Apr; 29(4):953-958. PubMed ID: 29351573
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility.
Ekholm M; Beglerbegovic S; Grabau D; Lövgren K; Malmström P; Hartman L; Fernö M
Histopathology; 2014 Aug; 65(2):252-60. PubMed ID: 24527721
[TBL] [Abstract][Full Text] [Related]
14. Comparative validation of the SP6 antibody to Ki67 in breast cancer.
Zabaglo L; Salter J; Anderson H; Quinn E; Hills M; Detre S; A'Hern R; Dowsett M
J Clin Pathol; 2010 Sep; 63(9):800-4. PubMed ID: 20671052
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.
Hicks D; Dell'Orto P; Falzon M; Hoff KD; Levy YY; McMahon L; Miller K; Russo L; Viale G
Appl Immunohistochem Mol Morphol; 2017; 25(5):313-319. PubMed ID: 26657878
[TBL] [Abstract][Full Text] [Related]
16. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.
Barbareschi M; Girlando S; Mauri FM; Forti S; Eccher C; Mauri FA; Togni R; Dalla Palma P; Doglioni C
Am J Clin Pathol; 1994 Aug; 102(2):171-5. PubMed ID: 8042584
[TBL] [Abstract][Full Text] [Related]
17. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
[TBL] [Abstract][Full Text] [Related]
18. A simple digital image analysis system for automated Ki67 assessment in primary breast cancer.
Alataki A; Zabaglo L; Tovey H; Dodson A; Dowsett M
Histopathology; 2021 Aug; 79(2):200-209. PubMed ID: 33590538
[TBL] [Abstract][Full Text] [Related]
19. Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors.
Hacking SM; Sajjan S; Lee L; Ziemba Y; Angert M; Yang Y; Jin C; Chavarria H; Kataria N; Jain S; Nasim M
Pathol Res Pract; 2020 Mar; 216(3):152753. PubMed ID: 31761497
[TBL] [Abstract][Full Text] [Related]
20. A Harmonization Study for the Use of 22C3 PD-L1 Immunohistochemical Staining on Ventana's Platform.
Neuman T; London M; Kania-Almog J; Litvin A; Zohar Y; Fridel L; Sandbank J; Barshak I; Vainer GW
J Thorac Oncol; 2016 Nov; 11(11):1863-1868. PubMed ID: 27664534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]